Geospiza Wins NIH Cancer Grant
Luke Timmerman10/7/09
Geospiza, the Seattle-based maker of software to help researchers analyze genomic data, said today it has been awarded a $110,000 Small Business Innovation Research Grant from the National Human Genome Research Institute to improve methods for spotting rare gene mutations that may determine how a cancer cell grows, and whether it will resist treatment.
Luke Timmerman is the National Biotech Editor of Xconomy, and the Editor of Xconomy Seattle. E-mail him at ltimmerman@xconomy.com or follow him on Twitter at twitter.com/ldtimmerman.
